Tel Aviv, Israel

Omer Refaeli

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Journey1, Inc., Notal Vision Inc.. Active years: 2007-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Omer Refaeli. Retrieved from https://idiyas.com/inventor/omer-refaeli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 35(Granted Patents)


Location History:

  • Givatayim, IL (2007)
  • Tel Aviv, IL (2020)

Company Filing History:


Years Active: 2007-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Omer Refaeli

Introduction: Omer Refaeli is a renowned inventor based in Tel Aviv, Israel, known for his groundbreaking contributions to various technological fields.

Latest Patents: Omer Refaeli holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse expertise and innovative mindset.

Career Highlights: With a background in engineering and a passion for problem-solving, Omer Refaeli has successfully developed and patented numerous inventions that have had a significant impact on their respective industries.

Collaborations: Throughout his career, Omer Refaeli has collaborated with leading research institutions, universities, and tech companies to further enhance his inventions and bring them to the market, solidifying his reputation as a forward-thinking inventor.

Conclusion: Omer Refaeli's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a standout figure in the world of inventors, with his work continuing to inspire future generations of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…